| 0173-0517 | These highlights do not include all the information needed to use FLOLAN safely and effectively. See full prescribing information for FLOLAN. FLOLAN (epoprostenol sodium) for injection, for intravenous use Initial U.S. Approval: 1995 | GlaxoSmithKline LLC |
| 0173-0517-00 | These highlights do not include all the information needed to use FLOLAN safely and effectively. See full prescribing information for FLOLAN. FLOLAN (epoprostenol sodium) for injection, for intravenous use Initial U.S. Approval: 1995 | GlaxoSmithKline LLC |
| 0173-0519 | These highlights do not include all the information needed to use FLOLAN safely and effectively. See full prescribing information for FLOLAN. FLOLAN (epoprostenol sodium) for injection, for intravenous use Initial U.S. Approval: 1995 | GlaxoSmithKline LLC |
| 0173-0519-00 | These highlights do not include all the information needed to use FLOLAN safely and effectively. See full prescribing information for FLOLAN. FLOLAN (epoprostenol sodium) for injection, for intravenous use Initial U.S. Approval: 1995 | GlaxoSmithKline LLC |
| 0173-0857 | These highlights do not include all the information needed to use FLOLAN safely and effectively. See full prescribing information for FLOLAN. FLOLAN (epoprostenol sodium) for injection, for intravenous use Initial U.S. Approval: 1995 | GlaxoSmithKline LLC |
| 0173-0857-02 | These highlights do not include all the information needed to use FLOLAN safely and effectively. See full prescribing information for FLOLAN. FLOLAN (epoprostenol sodium) for injection, for intravenous use Initial U.S. Approval: 1995 | GlaxoSmithKline LLC |
| 62756-059 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION. EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | Sun Pharmaceutical Industries, Inc. |
| 62756-059-40 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION. EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | Sun Pharmaceutical Industries, Inc. |
| 62756-060 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION. EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | Sun Pharmaceutical Industries, Inc. |
| 62756-060-40 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION. EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | Sun Pharmaceutical Industries, Inc. |
| 66215-402 | These highlights do not include all the information needed to use VELETRI safely and effectively. See full prescribing information for VELETRI. VELETRI ® (epoprostenol) for injection, for intravenous use Initial U.S. Approval: 1995 | Actelion Pharmaceuticals US, Inc. | Patheon Italia S.p.A. | Cayman Pharma s.r.o. | Wasserburger Arzneimittelwerk GmbH | AndersonBrecon Inc. |
| 66215-402-01 | These highlights do not include all the information needed to use VELETRI safely and effectively. See full prescribing information for VELETRI. VELETRI ® (epoprostenol) for injection, for intravenous use Initial U.S. Approval: 1995 | Actelion Pharmaceuticals US, Inc. | Patheon Italia S.p.A. | Cayman Pharma s.r.o. | Wasserburger Arzneimittelwerk GmbH | AndersonBrecon Inc. |
| 66215-403 | These highlights do not include all the information needed to use VELETRI safely and effectively. See full prescribing information for VELETRI. VELETRI ® (epoprostenol) for injection, for intravenous use Initial U.S. Approval: 1995 | Actelion Pharmaceuticals US, Inc. | Patheon Italia S.p.A. | Cayman Pharma s.r.o. | Wasserburger Arzneimittelwerk GmbH | AndersonBrecon Inc. |
| 66215-403-01 | These highlights do not include all the information needed to use VELETRI safely and effectively. See full prescribing information for VELETRI. VELETRI ® (epoprostenol) for injection, for intravenous use Initial U.S. Approval: 1995 | Actelion Pharmaceuticals US, Inc. | Patheon Italia S.p.A. | Cayman Pharma s.r.o. | Wasserburger Arzneimittelwerk GmbH | AndersonBrecon Inc. |
| 67457-587 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION . EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | Mylan Institutional LLC |
| 67457-587-10 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION . EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | Mylan Institutional LLC |
| 67457-588 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION . EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | Mylan Institutional LLC |
| 67457-588-10 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION . EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | Mylan Institutional LLC |
| 68083-642 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION. EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | Gland Pharma Limited |
| 68083-642-01 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION. EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | Gland Pharma Limited |
| 68083-707 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION. EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | Gland Pharma Limited |
| 68083-707-01 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION. EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | Gland Pharma Limited |